(2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, and Alice Fletcher, Lead Bariatric Dietitian, on 7 July 2025
It is degraded locally by the enzyme dipeptidyl peptidase-4 (DPP4) and minimally by the neutral endopeptidase, and it is eliminated by the kidney
Intestinal Dysbiosis and Probiotic Applications in Autoimmune Diseases
Other complications can include drug-induced lupus, a condition resembling lupus, and Stevens-Johnson syndrome, a rare, serious skin disorder
Simunkova et al
The key to reducing the impact of non-alcoholic fatty liver disease (NAFLD) is to intervene early, before inflammation and fibrosis progress